False-positivity results in rapid antigen tests for SARS-CoV-2: an umbrella review of meta-analyses and systematic reviews.
Yu-Pei YangLi-Li HuangShuang-Jun PanDan XuZhu Liduzi JiesisibiekeTao-Hsin TungPublished in: Expert review of anti-infective therapy (2022)
The false positivity rates in the included studies ranged from 0.0% - 4.0%. This study summarizes the available evidence on the incidence of false positivity in RADTs and shows it is less than 4.0%. Therefore, our findings imply that RADTs can be an appropriate, economic, and rapid detection method for mass screening of COVID-19.